Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer

PURPOSE: Radiation therapy dose escalation using a simultaneous integrated boost (SIB) is predicted to improve local tumor control in esophageal cancer; however, any increase in acute hematologic toxicity (HT) could limit the predicted improvement in patient outcomes. Proton therapy has been shown t...

Descripción completa

Detalles Bibliográficos
Autores principales: Warren, Samantha, Hurt, Christopher N., Crosby, Thomas, Partridge, Mike, Hawkins, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2017
Materias:
Physics Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612280/
https://www.ncbi.nlm.nih.gov/pubmed/29280467
http://dx.doi.org/10.1016/j.ijrobp.2017.07.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612280/
https://www.ncbi.nlm.nih.gov/pubmed/29280467
http://dx.doi.org/10.1016/j.ijrobp.2017.07.025

Ejemplares similares